Learn how Genentech is Automating Drug Research with Amazon Bedrock Agents

122 Views

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Feb 17, 2025

Learn how Genentech uses AWS Bedrock Agents to improve their drug research process, reducing manual work in biomarker validation. The solution automates about 43,200 hours (nearly 5 years) of work across different therapeutic areas which helps Genentech is speed up drug target identification and improve research efficiency, which may lead to faster drug development.

To learn more check out:
https://go.aws/3vC9RV8
https://go.aws/427KTcy

Subscribe to AWS: https://go.aws/subscribe

Sign up for AWS: https://go.aws/signup
AWS free tier: https://go.aws/free
Explore more: https://go.aws/more
Contact AWS: https://go.aws/contact

Next steps:
Explore on AWS in Analyst Research: https://go.aws/reports
Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace
Join the AWS Partner Network: https://go.aws/partners
Learn more on how Amazon builds and operates software: https://go.aws/library

Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb

Why AWS?
Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster.

#GenentechInnovation #AmazonBedrock #GenAIAgents #DrugDevelopment #AWSforLifeSciences #AWS #AmazonWebServices #CloudComputing